• Profile
Close

A trial of sertraline or cognitive behavior therapy for depression in epilepsy

Annals of Neurology Aug 02, 2019

Gilliam FG, Black K, Carter J, et al. - In this investigation involving 140 adult outpatients with epilepsy and current major depressive disorder, researchers assessed the effectiveness of sertraline vs cognitive behavior therapy (CBT) for depression, quality of life, seizures, and adverse treatment effects. Patients were randomized to sertraline or weekly CBT for 16 weeks. Investigators found that suicide risk at final evaluation was linked to persistent depression, but not sertraline or seizures. After sertraline or CBT, remission of depression was seen in in over one-half of people. Improving depression benefits quality of life despite the epilepsy-related complex psychosocial disability. Serotonin reuptake inhibition in people with epilepsy does not seem to boost seizures or suicidality.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay